Comparison between two locally delivered drugs in gums for the treatment of pyorrhea
Not Applicable
Completed
- Conditions
- Health Condition 1: K053- Chronic periodontitis
- Registration Number
- CTRI/2022/09/045816
- Lead Sponsor
- Dr Manali Gupte
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 56
Inclusion Criteria
Having at minimum two teeth with one proximal site with (clinical attachment level [CAL]) of 3–4 mm and (probing pocket depth [PPD]
of 5–6 mm) stage ll grade A.
Exclusion Criteria
Previous use of systemic or local antibiotic, anti-inflammatory drugs, probiotics,
or periodontal therapy in the previous 6 month.
Allergic to tetracycline.
Smokers.
Pregnant females.
The different group of drug should not be administered in adjacent areas of tooth.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical parameter that is pocket probing depth, clinical attachment level and bleeding on probing and height and percentage of bone fill.Timepoint: Baseline,3 months and 6 months <br/ ><br>bone fill - baseline and 9 months
- Secondary Outcome Measures
Name Time Method microbiological parameter ( colony forming unit -in porphynomonas gingivalis bacteria )Timepoint: at baseline, 3 months and 6 months